Clinical trial

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

NCT05517811

Study summary

ClinicalTrials.gov

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention TEG indices Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2022-06-26

PhaseN/A

Conditions

Liver Cancerverified · MONDO: liver cancer

Esophageal Cancerverified · MONDO: esophageal cancer

Colorectal Cancerverified · MONDO: colorectal cancer

Lung Adenocarcinomaverified · MONDO: lung adenocarcinoma

Controlunresolved

Pancreas Cancerverified · MONDO: malignant pancreatic neoplasm

Biliary Cancerunresolved

Interventions

TEG indicesDIAGNOSTIC_TEST

Sponsors & collaborators

University of Colorado, Denverlead sponsor

Haemonetics Corporationcollaborator

Mapped research locations

AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05517811 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.